UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2009-03-13
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 266
- Registration Number
- NCT00861094
- Locations
- 🇫🇷
Hopital Du Bocage, Dijon, France
🇫🇷Hopital Ambroise Pare, Boulogne-Billancourt, France
🇫🇷Hopital Saint Andre, Bordeaux, France
Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Biological: bevacizumab
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 100
- Registration Number
- NCT00820547
- Locations
- 🇫🇷
Centre Paul Papin, Angers, France
🇫🇷Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besancon, France
🇫🇷Institut Sainte Catherine, Avignon, France
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
- Conditions
- Colorectal CancerPrimary Peritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 264
- Registration Number
- NCT00769405
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷Institut Curie, Paris, France
🇫🇷Hopital de l'Archet CHU de Nice, Nice, France
Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 82
- Registration Number
- NCT00674414
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷Centre Oscar Lambret, Lille, France
🇫🇷Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, France
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
- Conditions
- brca1 Mutation CarrierBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)brca2 Mutation Carrier
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 170
- Registration Number
- NCT00673335
- Locations
- 🇫🇷
Hopital Arnaud de Villeneuve, Montpellier, France
🇫🇷Centre Hospitalier General de Niort, Niort, France
🇫🇷Centre Catherine de Sienne, Nantes, France
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 424
- Registration Number
- NCT00667069
- Locations
- 🇫🇷
Centre Hospitalier Universitaire Henri Mondor, Creteil, France
🇫🇷Clinique du Pont de Chaume, Montauban, France
🇫🇷Centre Henri Becquerel, Rouen, France
Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 116
- Registration Number
- NCT00629616
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷Hopital Dupuytren, Limoges Cedex, France
🇫🇷Centre Eugene Marquis, Rennes, France
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 762
- Registration Number
- NCT00630032
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇫🇷Centre Hospitalier Docteur Duchenne, Boulogne Sur Mer, France
🇺🇸CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
- Conditions
- Colorectal Cancer
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 19
- Registration Number
- NCT00541112
- Locations
- 🇫🇷
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Centre Rene Huguenin, Saint Cloud, France
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
- Conditions
- Kidney Cancer
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 92
- Registration Number
- NCT00541008
- Locations
- 🇫🇷
Hopital Saint Michel, Paris, France
🇫🇷CHU de la Timone, Marseille, France
🇫🇷Centre Paul Papin, Angers, France